US Oncology

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer2 trials
• Endometrial cancer1 trial
• Lung cancer1 trial
• Mantle cell lymphoma1 trial
• Ovarian cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 34 trials
• Phase 11 trial
• Phase 2/31 trial

Status

• Active, not recruiting5 trials
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company5 trials
• Loxo Oncology, Inc.1 trial

Running trials

• Recruiting

  A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  NCT07213804· Phase 3· Eli Lilly and Company· Source

  Contact: SMO Sarah Cannon Research Inst. (principal investigator)

• Active, not recruiting

  Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

  NCT05169567· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

  NCT04819100· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

  NCT04662255· Phase 3· Loxo Oncology, Inc.· Source

• Active, not recruiting

  A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer

  NCT04188548· Phase 1· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

  NCT03706365· Phase 2/3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ovarian cancer1 recruiting